Learn how we’re working with partners like the International Agency for the Prevention of Blindness to eliminate preventable blindness.

September 29 is World Heart Day. For the past six decades, Novartis has been working to advance heart health around the world.

Standing by people with sickle cell disease and their families

As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.

Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.

European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.

The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.

The first pan-African Novartis Social Business stakeholder dialogue took place in Kampala, Uganda, on March 20, 2019.